ClearPoint (CLPT) Enterprise Value to EBITDA Ratio
This chart of ClearPoint Neuro, Inc. (CLPT) asset value demonstrates an EV/EBITDA ratio of 0.00. ClearPoint Neuro, Inc. is developing a closed MRI-navigation ecosystem where clinics are fully dependent on proprietary software and consumables. The brand is recognized as the gold standard in precision neurosurgery due to the surgical accuracy of its systems. This non-cyclical sector relies on demographic trends and medical automation, ensuring stable demand.
Comprehensive metric breakdowns and analytics for clearpointneuro.com (CLPT)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio ClearPoint Neuro, Inc.|CLPT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity ClearPoint Neuro|CLPT - Company Total Debt|Debts to Book Capitalization ClearPoint Neuro, Inc.|CLPT - Long-Term Debt|Company Short-Term Debts ClearPoint Neuro|Quick Ratio clearpointneuro.com
- financial results and valuation multiples details:
CLPT - Net Financial Result|Projected Future Earnings ClearPoint Neuro, Inc.|CLPT - Price to Earnings Ratio|Forward P/E Multiple ClearPoint Neuro|CLPT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ClearPoint Neuro, Inc.|CLPT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months ClearPoint Neuro|CLPT - Earnings per share for the trailing year|Quarterly EPS earnings growth clearpointneuro.com|CLPT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year ClearPoint Neuro, Inc.
Analysis of all company metrics:ClearPoint CLPT
The active implementation of neuronavigation systems in hospitals creates a foundation for future growth despite current R&D cost pressures for ClearPoint Neuro, Inc. (CLPT). The EV/EBITDA trend, accounting for total debt, reflects the total enterprise value relative to operating profit before depreciation and amortization. This metric allows for an assessment of the asset's payback period by combining market capitalization and net debt. The stability of this indicator confirms the fundamental resilience of ClearPoint Neuro, Inc. (CLPT) during its scaling phase.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Autonomix Medical|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BBLG|EV/EBITDA Multiple AXNX|BIOL - Company Value to EBITDA|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
